As of 2025-07-21, the EV/EBITDA ratio of Sam Chun Dang Pharm Co Ltd (000250.KQ) is 361.92. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 000250.KQ's latest enterprise value is 3,962,583.50 mil KRW. 000250.KQ's TTM EBITDA according to its financial statements is 10,948.86 mil KRW. Dividing these 2 quantities gives us the above 000250.KQ EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 19.2x - 26.0x | 20.8x |
| Forward P/E multiples | 14.6x - 20.3x | 17.6x |
| Fair Price | 10,362.00 - 38,421.34 | 22,313.65 |
| Upside | -93.9% - -77.4% | -86.9% |
| Date | EV/EBITDA |
| 2025-07-17 | 361.92 |
| 2025-07-16 | 347.99 |
| 2025-07-15 | 352.70 |
| 2025-07-14 | 342.85 |
| 2025-07-11 | 341.13 |
| 2025-07-10 | 347.56 |
| 2025-07-09 | 347.56 |
| 2025-07-08 | 335.56 |
| 2025-07-07 | 327.42 |
| 2025-07-04 | 320.14 |
| 2025-07-03 | 328.71 |
| 2025-07-02 | 328.28 |
| 2025-07-01 | 306.42 |
| 2025-06-30 | 312.64 |
| 2025-06-27 | 323.13 |
| 2025-06-26 | 322.49 |
| 2025-06-25 | 332.35 |
| 2025-06-24 | 353.99 |
| 2025-06-23 | 353.56 |
| 2025-06-20 | 358.28 |
| 2025-06-19 | 342.42 |
| 2025-06-18 | 340.92 |
| 2025-06-17 | 351.63 |
| 2025-06-16 | 344.13 |
| 2025-06-13 | 342.85 |
| 2025-06-12 | 359.13 |
| 2025-06-11 | 348.20 |
| 2025-06-10 | 328.71 |
| 2025-06-09 | 326.35 |
| 2025-06-05 | 322.92 |
| 2025-06-04 | 308.14 |
| 2025-06-02 | 309.85 |
| 2025-05-30 | 310.92 |
| 2025-05-29 | 312.21 |
| 2025-05-28 | 316.92 |
| 2025-05-27 | 326.56 |
| 2025-05-26 | 322.28 |
| 2025-05-23 | 310.92 |
| 2025-05-22 | 303.85 |
| 2025-05-21 | 291.85 |
| 2025-05-20 | 277.50 |
| 2025-05-19 | 295.49 |
| 2025-05-16 | 314.14 |
| 2025-05-15 | 320.56 |
| 2025-05-14 | 318.42 |
| 2025-05-13 | 314.14 |
| 2025-05-12 | 289.28 |
| 2025-05-09 | 295.92 |
| 2025-05-08 | 298.92 |
| 2025-05-07 | 292.49 |